菌体治疗:当前的策略和未来的前景
Zihe Zhou1, Hanyu Fu2, Mengzhe Li3
1Department of Laboratory Medicine Peking University Third Hospital Beijing China.
MedComm
|March 4, 2026
概括
菌体疗法为抗生素提供了一个有希望的替代品,用于打击抗菌素耐药性. 本综述探讨了临床应用,先进的策略,如菌体-抗生素协同作用,以及在实施菌体治疗方面的挑战.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 抗菌素耐药性 (AMR) 是一个关键的全球卫生危机,需要新的治疗策略.
- 菌体 (菌体) 正在成为传统抗生素的可行替代品.
- 本综述侧重于菌体治疗的临床转化和先进应用.
研究的目的:
- 提供当前和新兴的菌体治疗应用的全面概述.
- 讨论提升菌素有效性和传递的先进策略.
- 突出临床实施的挑战和未来方向.
主要方法:
- 对菌体治疗的临床前和临床研究的文献综述.
- 分析先进的菌体工程技术和输送系统.
- 检查菌体在治疗多抗药性感染和医院感染中的应用.
主要成果:
- 菌体疗法在治疗多抗药性感染,预防医院感染和开发疫苗方面显示出潜力.
- 像菌体-抗生素协同作用和生物材料增强输送等策略可以提高菌体的稳定性和有效性.
- 基因工程可以扩大菌体宿主范围,并将温带菌体转化为菌体变体.
结论:
- 菌体疗法在解决AMR危机方面具有变革性的潜力.
- 需要进一步的研究和开发,以克服药理动力学,标准化和监管批准方面的挑战.
- 基于菌体的干预措施提供了从感染治疗到预防和疫苗开发的各种应用.
相关概念视频
Lytic Cycle of Bacteriophages
60.5K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.5K
Lysogenic Cycle of Bacteriophages
50.0K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
50.0K
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Viral Replication: Lysogenic Cycle
2.7K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.7K
DNA Bacteriophages
1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Human Virome
54
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
54


